Suppr超能文献

新生血管性黄斑变性:病因、危险因素及研究与治疗新进展综述。

Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy.

机构信息

Knights Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR 97403, USA.

Vagelos College of Physicians & Surgeons, Columbia Irving Medical Center, Columbia University, New York, NY 10032, USA.

出版信息

Int J Mol Sci. 2021 Jan 25;22(3):1170. doi: 10.3390/ijms22031170.

Abstract

Neovascular age-related macular degeneration (exudative or wet AMD) is a prevalent, progressive retinal degenerative macular disease that is characterized by neovascularization of the choroid, mainly affecting the elderly population causing gradual vision impairment. Risk factors such as age, race, genetics, iris color, smoking, drinking, BMI, and diet all play a part in nvAMD's progression, with anti-vascular endothelial growth factor (anti-VEGF) therapy being the mainstay of treatment. Current therapeutic advancements slow the progression of the disease but do not cure or reverse its course. Newer therapies such as gene therapies, Rho-kinase inhibitors, and levodopa offer potential new targets for treatment.

摘要

新生血管性年龄相关性黄斑变性(渗出性或湿性 AMD)是一种普遍存在的、进行性的视网膜退行性黄斑疾病,其特征是脉络膜新生血管形成,主要影响老年人群,导致视力逐渐下降。年龄、种族、遗传、虹膜颜色、吸烟、饮酒、BMI 和饮食等风险因素都与 nvAMD 的进展有关,抗血管内皮生长因子(anti-VEGF)治疗是该病的主要治疗方法。目前的治疗进展虽然可以减缓疾病的进展,但不能治愈或逆转其病程。基因治疗、Rho-激酶抑制剂和左旋多巴等新疗法为治疗提供了新的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ea/7866170/117d3c7173cd/ijms-22-01170-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验